Turner Syndrome clinical trials

Explore recruiting turner syndrome clinical trials.

Recruiting turner syndrome studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Turner Syndrome trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Endocrine, Cardiovascular, Pharmacological, and Physiological Aspects of Sex Hormone Therapy in Turner Syndrome - Study 2

Denmark

Therapeutic use (Phase IV) EU CTIS Study details

Testosterone Replacement Therapy in Women with Turner Syndrome – Endocrine, Cardiovascular, Physiological, Neurocognitive and Genomic effects

Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

Endocrine, Cardiovascular, Pharmacological, and Physiological Aspects of Sex Hormone Therapy in Turner Syndrome - Study 1

Denmark

Therapeutic use (Phase IV) EU CTIS Study details

A study evaluating the safety and efficacy of once-weekly dosing of somapacitan in a basket study design in paediatric participants with short stature either born small of gestational age or with Turner syndrome, Noonan syndrome or idiopathic short stature

Netherlands, Poland, Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

A study comparing the effect and safety of once weekly dosing of somapacitan with daily Norditropin® as well as evaluating long-term safety of somapacitan in a basket study design in children with short stature either born small for gestational age or with Turner syndrome, Noonan syndrome, or idiopathic short stature

Austria, Poland, Portugal, Spain, Croatia, Italy +10 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

HighLiGHts - A Pivotal, Parallel-Arm, Phase 3, Open-Label, Active-controlled, Global, Multicenter, Randomized Basket Trial Investigating the Efficacy and Safety of Once-weekly Lonapegsomatropin Compared to Daily Somatropin in Prepubertal Children and Adolescents with Growth Failure or Short Stature due to Growth Hormone Sufficient Disorders – Turner Syndrome, SHOX Deficiency, Small for Gestational Age, and Idiopathic Short Stature

Germany, Spain, Italy, France, Romania

Therapeutic confirmatory (Phase III) EU CTIS Study details

Turner Syndrome trials by city

Turner Syndrome in Toronto Turner Syndrome in Vancouver Turner Syndrome in Montreal Turner Syndrome in Calgary Turner Syndrome in Edmonton Turner Syndrome in Ottawa Turner Syndrome in Winnipeg Turner Syndrome in Quebec City Turner Syndrome in Hamilton Turner Syndrome in Kitchener Turner Syndrome in London Turner Syndrome in Halifax Turner Syndrome in New York Turner Syndrome in Los Angeles Turner Syndrome in Chicago Turner Syndrome in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease